NCT06097728 2026-03-04
eVOLVE-Meso
AstraZeneca
Phase 3 Recruiting
Clinical Trials
11 trialsNCT06513962 2026-02-24
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Children's Oncology Group
Phase 3 Recruiting
NCT06395441 2025-12-26
Wisconsin Ginseng for Decreasing Cancer Related Fatigue
Mayo Clinic
Phase 3 Recruiting
NCT07174453 2025-12-08
Trial to Evaluate irAEs With Different Standard of Care Dosing Strategies of Standard of Care Immunotherapies
University of Kansas Medical Center
Phase 3 Recruiting
NCT06587490 2025-10-14
TRITONS
University of California, San Diego
Phase 3 Recruiting
NCT06658353 2025-03-20
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3 Recruiting
NCT04996017 2025-03-13
AtezoMeso
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3 Recruiting
NCT06762405 2025-02-18
PREDIR-NEOREC
Centre Hospitalier Universitaire Dijon
Phase 3 Recruiting
NCT06208917 2024-01-17
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
Sun Yat-sen University
Phase 3 Recruiting
NCT05080010 2021-10-15
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting
NCT04799002 2021-03-16
Topotecan and Melphalan for Retinoblastoma
Sun Yat-sen University
Phase 3 Recruiting